
EXIT071
Using cutting-edge biomarker technology, Leiden-based EXIT071 is developing an industry-shifting method for fast, precise and non-invasive diagnostics, novel therapeutics and biotechnology. By isolating and analysing exosomes - nanoparticles that come directly from cells and are filled with the same molecules as parental cells - EXIT071 is able to form a snapshot of the health of cells and organs and spot potential diseases.